Advisory panel recommends FDA approval of new emergency contraceptive
An important step has been made towards a future FDA approval of the safe emergency-contraceptive option for women, ella®.
An expert advisory panel recommended approval to the Food and Drug Administration (FDA). The panel's recommendation of approval comes after more than 4,000 women participated in a rigorous clinical trial for the emergency contraceptive. The research shows the medication can be an effective way to prevent pregnancy up to five days after sex.
This is a great step forward as another option for pregnancy prevention for women in Oregon and throughout the US.
Even with this great news, we still expect that anti-choice groups will attack the expert panel's decision and distort the facts about ella®, which occurred similarly with efforts to delay the FDA's approval of over-the-counter access to emergency contraception during the Bush administration.
Anti-choice groups will try to get this labeled an abortifacient although its primary action is simply preventing pregnancy by interfering with ovulation.
We will keep you updated as the process continues. In the meantime, we are counting on you to get involved in our Emergency Birth Control Access Project, to make sure women in Oregon know about their reproductive options.
|
